OBJECTIVE
Cenobamate is approved for treatment of focal seizures in adults, but evidence on non-seizure outcomes remains limited. This interim statistical analysis of the cenoBamate in aduLts with focal-onsEt SeizureS (BLESS) study evaluated patient- and clinician-reported outcomes for up to 52 weeks of cenobamate trea...
Simona Lattanzi, G. d'Orsi, M. T. Di Claudio et al.· Epilepsia· 0 citations
OBJECTIVE
Preclinical evidence supports the role of statins as antiepileptogenic agents. In this study, we investigated the risk of remote unprovoked seizures (RS) according to the use of statin therapy in a cohort of first-ever status epilepticus (SE) survivors.
METHODS
Retrospective analysis was made of adult patie...
Niccolò Orlandi, G. Giovannini, Lisa Taruffi et al.· Epilepsia· 0 citations
Heterogeneity exists within the spectrum of acute symptomatic causes; distinct etiological subcategories may carry different risks of refractoriness and superrefractoriness.
Simona Lattanzi, G. Giovannini, Niccolò Orlandi et al.· Epilepsia· 2 citations· ⚡1
The ACARD score is a user-friendly tool developed to predict 30-day mortality after nonhypoxic SE and has the potential to identify participants at high risk of short-term mortality and outperform the performance of other available scoring systems.
Simona Lattanzi, E. Trinka, P. Bosque-Varela et al.· Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.